Share on LinkedInShare on LinkedIn

ARTICLE · 21 FEBRUARY 2012

SEC & DOJ Settle Bribery Charges Against Smith & Nephew

The U.S. Securities and Exchange Commission (SEC) announced on Monday a settlement with London-based medical device company Smith & Nephew PLC to resolve charges that the company violated the US Foreign Corrupt Practices Act (FCPA) when its US and German subsidiaries bribed public doctors in Greece.

United StatesCriminal Law

The U.S. Securities and Exchange Commission (SEC) announced on Monday a settlement with London-based medical device company Smith & Nephew PLC to resolve charges that the company violated the US Foreign Corrupt Practices Act (FCPA) when its US and German subsidiaries bribed public doctors in Greece.  Putting the Smith & Nephew settlement in context, Nathalie Tadena of the Wall Street Journal explains:

The settlement came as US authorities have stepped up enforcement of the [FCPA], which bars US companies from bribing foreign officials.  Smith & Nephew and other medical-device companies were asked by the SEC and the Justice Department [DOJ] in late 2007 to look into possible improper payments to government-employed doctors and to voluntarily report any issues.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from